---
title: "动脉粥样硬化与免疫失衡"
date: 2026-01-21T00:25:02Z
draft: ["false"]
tags: [
  "fetched",
  "闲谈 Immunology"
]
categories: ["Acdemic"]
---
动脉粥样硬化与免疫失衡 by 闲谈 Immunology
------
<div><p data-pm-slice="0 0 []"><span leaf=""><span textstyle="">动脉粥样硬化的本质是</span></span><strong><span leaf=""><span textstyle="">慢性免疫失衡驱动的炎症性疾病</span></span></strong><span leaf=""><span textstyle="">，免疫失衡贯穿病变从启动、进展到并发症发生的全阶段，核心表现为骨髓造血异常、髓系细胞募集活化失控及斑块内免疫微环境紊乱。</span></span></p><section nodeleaf=""><img data-aistatus="1" data-imgfileid="100002898" data-ratio="1.2776911076443058" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/OTqlKiaoeWib5ib4q88WpibQBxMGBnAmdUcicFLUFUKMVKVCQ3fPRHlGJ1ichTZHgg3BYibVibPPkQ0zdBrD8n7PichzG2g/640?wx_fmt=png&amp;from=appmsg#imgIndex=0" data-type="png" data-w="641" type="block" src="https://mmbiz.qpic.cn/mmbiz_png/OTqlKiaoeWib5ib4q88WpibQBxMGBnAmdUcicFLUFUKMVKVCQ3fPRHlGJ1ichTZHgg3BYibVibPPkQ0zdBrD8n7PichzG2g/640?wx_fmt=png&amp;from=appmsg#imgIndex=0"></section><p><span data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{},"namespaceURI":"http://www.w3.org/1999/xhtml"}]'><span leaf=""><span textstyle="">10.1038/s41419-024-07166-8.</span></span></span></p><h3><span leaf=""><span textstyle="">免疫失衡的源头：骨髓造血功能扰动</span></span></h3><p><span leaf=""><span textstyle="">传统心血管风险因素（如高胆固醇、高血糖）、感染、衰老等会通过 “训练免疫”“应急造血” 等机制，破坏骨髓造血稳态，生成具有</span></span><strong><span leaf=""><span textstyle="">促炎偏向的髓系细胞</span></span></strong><span leaf=""><span textstyle="">，为动脉粥样硬化埋下基础。</span></span></p><ol><li><strong><span leaf=""><span textstyle="">代谢紊乱的影响</span></span></strong><section><span leaf=""><span textstyle="">高胆固醇会导致造血干细胞（HSC）膜胆固醇堆积，促进其增殖并偏向生成单核细胞、中性粒细胞；高血糖则加速 HSC 分裂，增加促炎髓系细胞输出。</span></span></section></li><li><strong><span leaf=""><span textstyle="">感染与应急造血</span></span></strong><section><span leaf=""><span textstyle="">流感、败血症等急性感染会触发 “应急髓系生成”，优先产生单核细胞、中性粒细胞（牺牲淋巴细胞生成），这些细胞会加剧血管炎症，甚至直接促进斑块破裂。</span></span></section></li><li><strong><span leaf=""><span textstyle="">衰老与克隆造血</span></span></strong><section><span leaf=""><span textstyle="">随年龄增长，HSC 逐渐偏向髓系生成（中性粒细胞 / 淋巴细胞比值升高）；部分 HSC 还会发生体细胞突变（如 TET2、JAK2 突变，即 CHIP），生成的髓系细胞会过度激活炎症小体（如 NLRP3），释放 IL-1β，加速斑块进展。</span></span></section></li></ol><h3><span leaf=""><span textstyle="">免疫失衡的关键环节：髓系细胞异常募集与活化</span></span></h3><p><span leaf=""><span textstyle="">血管内皮功能障碍是免疫细胞进入血管壁的 “入口”，而趋化因子轴、血小板 / 中性粒细胞的辅助作用，进一步放大了髓系细胞的募集和活化，形成 “炎症恶性循环”。</span></span></p><ol><li><strong><span leaf=""><span textstyle="">内皮功能障碍与 “入口” 开放</span></span></strong><section><span leaf=""><span textstyle="">动脉分支、弯曲处的血流紊乱，叠加高血压、高血糖等风险因素，会导致内皮细胞表达黏附分子（如 VCAM-1、ICAM-1）和趋化因子（如 CCL2），为单核细胞、中性粒细胞黏附血管壁提供条件。</span></span></section></li><li><strong><span leaf=""><span textstyle="">趋化因子轴的 “导向作用”</span></span></strong><section><span leaf=""><span textstyle="">CCL2-CCR2 是核心趋化轴 —— 经典单核细胞（高表达 CCR2）会被血管壁的 CCL2 吸引，穿越内皮进入斑块；同时，该轴还调控单核细胞从骨髓释放，双重促进其向斑块聚集。</span></span></section></li><li><strong><span leaf=""><span textstyle="">血小板与中性粒细胞的 “辅助激活”</span></span></strong><section><span leaf=""><span textstyle="">血小板会在病变处沉积预存的趋化因子（如 CCL5、CXCL4），增强单核细胞黏附；中性粒细胞则释放 NETs（中性粒细胞胞外陷阱），通过 DNA 链和组蛋白促进单核细胞 adhesion，并激活巨噬细胞炎症反应。</span></span></section></li></ol><h3><span leaf=""><span textstyle="">免疫失衡的核心表现：斑块内免疫微环境紊乱</span></span></h3><p><span leaf=""><span textstyle="">斑块内免疫细胞功能失衡（促炎＞抗炎）是病变进展和不稳定的直接原因，其中</span></span><strong><span leaf=""><span textstyle="">巨噬细胞功能异常</span></span></strong><span leaf=""><span textstyle="">和</span></span><strong><span leaf=""><span textstyle="">炎症小体过度激活</span></span></strong><span leaf=""><span textstyle="">最为关键。</span></span></p><ol><li><strong><span leaf=""><span textstyle="">巨噬细胞的 “双重角色” 失衡</span></span></strong></li></ol><ul><li><section><span leaf=""><span textstyle="">促炎端：脂质贫乏的巨噬细胞会高表达 IL-1β、TNF 等细胞因子，激活 NLRP3/Aim2 炎症小体，加剧局部炎症；</span></span></section></li><li><section><span leaf=""><span textstyle="">保护端：TREM2 + 巨噬细胞（泡沫细胞主要类型）可通过增强胆固醇流出、抑制细胞凋亡维持斑块稳定，但当风险因素持续存在时，其保护作用会被促炎信号压制。</span></span></section></li></ul><li><strong><span leaf=""><span textstyle="">胞葬作用缺陷</span></span></strong><section><span leaf=""><span textstyle="">巨噬细胞清除凋亡细胞的 “胞葬作用” 是炎症消退的关键，但随斑块进展，凋亡细胞表面 “不要吃我” 信号（如 CD47）升高，同时巨噬细胞的胞葬受体（如 MERTK）表达下降，导致坏死细胞堆积形成 “坏死核心”，进一步放大炎症。</span></span></section></li><section><span leaf=""><span textstyle="">参考资料</span></span></section><p><span leaf=""><span textstyle="">Inflammation in atherosclerosis: Lessons and therapeutic implications， Immunity 58, October 14, 2025， https://doi.org/10.1016/j.immuni.2025.09.012</span></span></p><p><span leaf=""><span textstyle="">Inflammation in atherosclerosis: pathophysiology and mechanisms，Cell Death Dis. 2024 Nov 11;15(11):817. doi: 10.1038/s41419-024-07166-8.</span></span></p><p><span leaf=""><span textstyle="">Targeting inflammation in atherosclerosis - from experimental insights to the clinic，Nat Rev Drug Discov. 2021 Aug;20(8):589-610. doi: 10.1038/s41573-021-00198-1.</span></span></p><section nodeleaf=""><mp-common-profile data-pluginname="mpprofile" data-nickname="闲谈 Immunology" data-alias="xiantanimmunology" data-from="0" data-headimg="http://mmbiz.qpic.cn/mmbiz_png/PSAKibajvwRY6ibhAvU9rdNiaEpUcd81BfRIs9SDSpC2mxkv8CcrI1F3TAMZhyj7AsnsPpCFfz599XUdudV23nILA/0?wx_fmt=png" data-signature="专注ImmunoBiology，桥接基础研究与产业应用！" data-id="MzYzMzUzNjcyNw==" data-is_biz_ban="0" data-service_type="1" data-verify_status="2"></mp-common-profile></section><p><mp-style-type data-value="3"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/gsFTVV_Ll7_35uFGjtJebw",target="_blank" rel="noopener noreferrer">原文链接</a>
